Ipca Laboratories Limited (IPCALAB.NS) NSE

Currency In INR

Key Executives

Name	Title	Pay	Year Born
Pranay Godha	Chief Executive Officer, MD & Executive Director	99.51M	1972
Prashant Premchand Godha	Executive Director	69.98M	1974
Ajit Kumar Bhanwarlal Jain	Chief Financial Officer, MD & Executive Director	106.02M	1955
Premchand Godha A.	Executive Chairman	149.65M	1947
Anil Kumar Pareek	President of Medical Affairs & Clinical Research	0	1957
Pabitra Kumar Kalipada Bhattacharyya	President of Operations- API	0	1969
Sameer S. Tamhane	Senior Vice President of Human Resources	0	1967
Kavita N. Sehwani	President of Generics	0	1971
Ashok Kumar	President of R&D - Chemicals	0	1954
Harish Kamath	Compliance Officer, Corporate Counsel & Company Secretary	0	1959
Pawan Kothari	Vice President of Operations	0	1965
Saidutta Nanda	President of Human Resources	0	N/A
Sunil Ghai	President of Marketing	0	1963
Vishnu Saran Singh Kushwaha	Vice President of Technical	0	1968

Name

Title

Pay

Year Born

Pranay Godha

Chief Executive Officer, MD & Executive Director

99.51M

1972

Prashant Premchand Godha

Executive Director

69.98M

1974

Ajit Kumar Bhanwarlal Jain

Chief Financial Officer, MD & Executive Director

106.02M

1955

Premchand Godha A.

Executive Chairman

149.65M

1947

Anil Kumar Pareek

President of Medical Affairs & Clinical Research

1957

Pabitra Kumar Kalipada Bhattacharyya

President of Operations- API

1969

Sameer S. Tamhane

Senior Vice President of Human Resources

1967

Kavita N. Sehwani

President of Generics

1971

Ashok Kumar

President of R&D - Chemicals

1954

Harish Kamath

Compliance Officer, Corporate Counsel & Company Secretary

1959

Pawan Kothari

Vice President of Operations

1965

Saidutta Nanda

President of Human Resources

N/A

Sunil Ghai

President of Marketing

1963

Vishnu Saran Singh Kushwaha

Vice President of Technical

1968

Description

Ipca Laboratories Limited, an integrated pharmaceutical company, manufactures and markets formulations and active pharmaceutical ingredients (APIs) for various therapeutic segments in India, Europe, Africa, the Americas, Asia, the Commonwealth of Independent States, and Australasia. The company offers APIs in anti-hypertensive, anti-malarial, diuretic, DMARD, anti-hypertensive, and anthelmintic therapeutic areas. It also provides generic and branded formulations in various therapeutic segments, including allergy, anti-neoplastic/cancer drugs, anti-arthritic, anti-epileptic, anti-hypertensive, cardiology, diabetes, dermatology, diabetology, emollients/protectives, fever, gastroenterology, helminthics, hepatoprotectives, immunosuppressant, infectious diseases, malaria, neurology, neuropathic pain, and NSAIDs, as well as nutraceuticals, ophthalmology, oral anti diabetes drug, orthopedics, probiotics, psychiatry, respiratory, rheumatology, and urology. The company also exports its products worldwide. Ipca Laboratories Limited was incorporated in 1949 and is based in Mumbai, India.